Abstract: The present invention provides, inter alia, methods for systemically treating or preventing graft-versus-host disease (GVHD) in a subject using a GLP-2 analogue or GLP-2 agonist. Also provided are methods for treating an autoimmune disorder in a subject, methods for improving the effect of a cancer treatment in a subject in need thereof, methods for systemically treating an inflammatory condition in a subject caused by solid organ transplant rejection, and methods for reducing high-dose chemotherapy- and/or radiotherapy-induced GI mucositis, using a GLP-2 analogue or GLP-2 agonist.

Abstract: There is provided a method of improving the use of the capacity of an ultra wideband network, the network comprising a plurality of channels the network further comprising a plurality of devices, each device forming a respective beacon group on a first one of the channels, each beacon group including at least one other device in the plurality of devices; the method comprising transmitting data from a first device in a beacon group using a channel other than the first channel whilst a second device in the beacon group transmits data using the first channel.

Abstract: There is provided a method of operating a device to join a network, the network having a plurality of superframes, each superframe being divided into slots, the method comprising transmitting a beacon frame in a first slot of a first superframe; wherein, if a collision occurs in the first slot, selecting a second slot from a group comprising the first slot and a plurality of slots occurring after the first slot; and transmitting a further beacon frame in the second slot in a subsequent superframe.